IDH1-MUTANT GLIOMA

Clinical trials for IDH1-MUTANT GLIOMA explained in plain language.

Never miss a new study

Get alerted when new IDH1-MUTANT GLIOMA trials appear

Sign up with your email to follow new studies for IDH1-MUTANT GLIOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1

New pill targets genetic flaw in aggressive brain cancers

Disease control Recruiting now

This study is testing an oral drug called safusidenib for adults with specific types of brain tumors that have a genetic change called an IDH1 mutation. The main goal is to see if the drug can safely control the tumor and delay its growth or return after standard treatments. The …

Matched conditions: IDH1-MUTANT GLIOMA

Phase: PHASE3 • Sponsor: Nuvation Bio Inc. • Aim: Disease control

Last updated Apr 01, 2026 14:41 UTC

IDH1-MUTANT GLIOMA

Get alerted when new IDH1-MUTANT GLIOMA trials appear

New pill targets genetic flaw in aggressive brain cancers